A detailed history of Geode Capital Management, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Geode Capital Management, LLC holds 7,265,786 shares of RPRX stock, worth $176 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,265,786
Previous 6,848,296 6.1%
Holding current value
$176 Million
Previous $181 Million 13.82%
% of portfolio
0.02%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$25.63 - $29.27 $10.7 Million - $12.2 Million
417,490 Added 6.1%
7,265,786 $206 Million
Q2 2024

Aug 09, 2024

BUY
$26.26 - $29.9 $7.88 Million - $8.98 Million
300,242 Added 4.59%
6,848,296 $181 Million
Q1 2024

May 13, 2024

BUY
$27.46 - $31.33 $4.95 Million - $5.65 Million
180,443 Added 2.83%
6,548,054 $199 Million
Q4 2023

Feb 13, 2024

BUY
$26.21 - $29.22 $6.97 Million - $7.77 Million
266,057 Added 4.36%
6,367,611 $179 Million
Q3 2023

Nov 13, 2023

SELL
$26.26 - $31.38 $1.16 Million - $1.39 Million
-44,310 Reduced 0.72%
6,101,554 $166 Million
Q2 2023

Aug 11, 2023

BUY
$29.6 - $36.56 $4.55 Million - $5.62 Million
153,738 Added 2.57%
6,145,864 $189 Million
Q1 2023

May 15, 2023

BUY
$32.77 - $39.4 $5.42 Million - $6.51 Million
165,332 Added 2.84%
5,992,126 $216 Million
Q4 2022

Feb 13, 2023

BUY
$39.17 - $44.04 $21.7 Million - $24.4 Million
555,060 Added 10.53%
5,826,794 $230 Million
Q3 2022

Nov 14, 2022

BUY
$39.88 - $44.65 $8.8 Million - $9.85 Million
220,646 Added 4.37%
5,271,734 $212 Million
Q2 2022

Aug 12, 2022

BUY
$37.53 - $44.22 $1.56 Million - $1.83 Million
41,439 Added 0.83%
5,051,088 $212 Million
Q1 2022

May 13, 2022

SELL
$37.46 - $42.44 $11 Million - $12.5 Million
-294,473 Reduced 5.55%
5,009,649 $195 Million
Q4 2021

Feb 11, 2022

BUY
$35.17 - $42.48 $40 Million - $48.3 Million
1,136,073 Added 27.26%
5,304,122 $211 Million
Q3 2021

Nov 12, 2021

BUY
$36.14 - $42.24 $78.9 Million - $92.2 Million
2,183,363 Added 110.01%
4,168,049 $151 Million
Q2 2021

Aug 13, 2021

BUY
$39.85 - $46.63 $2.16 Million - $2.53 Million
54,236 Added 2.81%
1,984,686 $81.2 Million
Q1 2021

May 12, 2021

BUY
$42.34 - $52.82 $28.7 Million - $35.8 Million
677,943 Added 54.13%
1,930,450 $84.1 Million
Q4 2020

Feb 12, 2021

BUY
$36.12 - $50.05 $6.06 Million - $8.39 Million
167,664 Added 15.46%
1,252,507 $62.6 Million
Q3 2020

Nov 13, 2020

BUY
$38.56 - $48.36 $9.82 Million - $12.3 Million
254,569 Added 30.66%
1,084,843 $45.6 Million
Q2 2020

Aug 13, 2020

BUY
$44.5 - $52.11 $36.9 Million - $43.3 Million
830,274 New
830,274 $40.3 Million

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.